Skip to main content

Table 3 Analysis for joint preservation

From: Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study

N = 95 Joint status after final surgery Chi-square analysis Logistic analysis
Preserve Sacrifice P value X2 value Standardized coefficient (B) Relative risk (eB) 95 % CI P value
Age grade ≤ 35 50 12       
> 35 22 10 0.197 1.666 0.934 2.546 0.853–7.600 0.094
Gender F 37 8       
M 35 14 0.217 1.524 0.575 1.777 0.606–5.209 0.295
Patient status Group P 67 17       
Group R 5 5 0.036 4.415 0.987 2.683 0.548–13.139 0.223
Campanacci Grade I or II 62 14       
III 10 8 0.019 5.498 1.172 3.230 0.957–10.903 0.059
Recurrence type Repetitive 19 9 0.0192 1.699 0.475 0.622 0.200–1.930 0.411
Single 53 13